Edition:
United Kingdom

OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

145JPY
6:00am GMT
Change (% chg)

¥-5 (-3.33%)
Prev Close
¥150
Open
¥150
Day's High
¥151
Day's Low
¥145
Volume
907,400
Avg. Vol
1,042,627
52-wk High
¥251
52-wk Low
¥139

Summary

Name Age Since Current Position

Kazuo Yamamoto

57

Takuya Tsunoda

54 2014 Director

Hiroshi Yamaji

53 2005 Director

Toyomasa Katagiri

47 2010 Independent Director

Biographies

Name Description

Kazuo Yamamoto

Mr. Kazuo Yamamoto resigned from the position of President and Representative Director of OncoTherapy Science, Inc. effective November 30, 2018. He joined the Company in July 2007. He used to work Tokyo Style Co., Ltd. and other two companies.

Takuya Tsunoda

Mr. Takuya Tsunoda has been serving as Director in OncoTherapy Science, Inc. since July 1, 2014. He is also working for another company and University of Tokyo. His previous titles include Vice President and Chief Director of Research and Development. He used to work for City of Hope National Cancer Institute, Wakayama Medical University, and another company.

Hiroshi Yamaji

Mr. Hiroshi Yamaji has been serving as Director in OncoTherapy Science, Inc. since June 2005. He is holding directorship in an affiliated company and a subsidiary. He joined the Company in February 2003. His previous titles include Director of Development and Director of Business Development. He used to work in a few companies, including Sankyo Co., Ltd., Eli Lilly Japan K.K., sanofi-aventis K.K., GlaxoSmithKline, as well as Pfizer Japan Inc.

Toyomasa Katagiri

Mr. Toyomasa Katagiri has been serving as Independent Director in OncoTherapy Science Inc since June 25, 2010. He is also working for The University of Tokushima as Professor. He used to work for The Institute of Medical Science, The University of Tokyo.

Basic Compensation

Options Compensation